This playbook explains why medical treatments and interventions must be tested within the populations that require them.
Developing drugs and therapies that naturally have a direct impact on the health and well-being of its users means is there a scientific obligation to ensure validity. For example, the underrepresentation of communities in tested populations, as we have witnessed in recent years, contorts patient data, resulting in a failure to meet the scientific rigor a clinical trial must demand.
In this playbook, explore why representation must be improved in clinical trials, and why it is so crucial, including the following benefits:
- More accurate safety and efficacy data
- Results that can be generalized
- Increased medical trust among underrepresented communities
Offered Free by: BioPharma Dive’s studioID and WCG
See All Resources from: BioPharma Dive’s studioID and WCG
